Rapamycin and Low-dose IL-2 Mediate an Immunosuppressive Microenvironment to Inhibit Benign Prostatic Hyperplasia.
Cao T, Xie F, Shi Y, Xu J, Liu Y, Cui D, Zhang F, Lin L, Li W, Gao Y, Ruan Y, Wang X, Zhu Y, Han B, Xia S, Guo W, Li B, Jing Y.
Cao T, et al. Among authors: guo w.
Int J Biol Sci. 2023 Jul 3;19(11):3441-3455. doi: 10.7150/ijbs.85089. eCollection 2023.
Int J Biol Sci. 2023.
PMID: 37497009
Free PMC article.